Altium Capital Management »

Unicycive Therapeutics shares owned by Altium Capital Management

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Unicycive Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.001600.835k600.8355k600.836k600.8365k600.837k1.472999M1.4729995M1.473M1.4730005M1.473001M
Value ($)Share countHistorical UNCY position of Altium Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $601k 1.5M 0.41

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Sarepta Therapeutics (SRPT)
Edwards Lifesciences (EW)
Xenon Pharmaceuticals (XENE)
Zevra Therapeutics Com New (ZVRA)
Intra Cellular Therapies (ITCI)
Soleno Therapeutics (SLNO)
Glaukos (GKOS)
Insmed Com Par $.01 (INSM)
Merit Medical Systems (MMSI)
Rezolute Com New (RZLT)
Vaxcyte (PCVX)
Avadel Pharmaceuticals Com Shs (AVDL)
Viking Therapeutics (VKTX)

View all positions for Altium Capital Management

Top funds holding Unicycive Therapeutics

Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Octagon Capital Advisors
Vivo Capital
Logos Global Management
Walleye Trading Advisors
Silverarc Capital Management
Longwood Capital Partners
Alyeska Investment Group
Altium Capital Management
Vanguard Group
Geode Capital Management
XTX Topco
State Street Corporation
Goldman Sachs Group

View all funds holding Unicycive Therapeutics